Morbidity and mortality in schizophrenia with comorbid substance use disorders

OBJECTIVE: Schizophrenia is highly comorbid with substance use disorders (SUD) but large epidemiological cohorts exploring the prevalence and prognostic significance of SUD are lacking. Here, we investigated the prevalence of SUD in patients with schizophrenia in Finland and Sweden, and the effect o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lähteenvuo, Markku, Batalla, Albert, Luykx, Jurjen J., Mittendorfer‐Rutz, Ellenor, Tanskanen, Antti, Tiihonen, Jari, Taipale, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359349/
https://www.ncbi.nlm.nih.gov/pubmed/33650123
http://dx.doi.org/10.1111/acps.13291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359349/
https://www.ncbi.nlm.nih.gov/pubmed/33650123
http://dx.doi.org/10.1111/acps.13291

Ejemplares similares